miR-874 has been reported to target AQP3 in gastric cancer (GC) (Jiang et al., 2014), pancreatic ductal adenocarcinoma (PDAC) (Huang et al., 2017) and non-small cell lung cancer (NSCLC) (Wang et al., 2020). Here, AQP3 is linked to gastric cancer.